MENU
+Compare
RARE
Stock ticker: NASDAQ
AS OF
Apr 23 closing price
Price
$37.31
Change
+$1.40 (+3.90%)
Capitalization
3.37B

RARE Ultragenyx Pharmaceutical Forecast, Technical & Fundamental Analysis

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company... Show more

Industry: #Biotechnology
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RARE with price predictions
Apr 23, 2025

RARE's RSI Indicator ascends from oversold territory

The RSI Oscillator for RARE moved out of oversold territory on April 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 40 similar instances when the indicator left oversold territory. In of the 40 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on RARE as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RARE just turned positive on April 14, 2025. Looking at past instances where RARE's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RARE advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

RARE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RARE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RARE entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.210) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (5.804) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RARE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RARE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RARE is expected to report earnings to rise 12.23% to -155 cents per share on May 01

Ultragenyx Pharmaceutical RARE Stock Earnings Reports
Q1'25
Est.
$-1.56
Q4'24
Missed
by $0.05
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.14
Q1'24
Missed
by $0.28
The last earnings report on February 13 showed earnings per share of -138 cents, missing the estimate of -134 cents. With 966.18K shares outstanding, the current market capitalization sits at 3.37B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KLCCX9.17N/A
N/A
Federated Hermes Kaufmann Large Cap C
VIVIX63.32N/A
N/A
Vanguard Value Index I
WFTCX4.37N/A
N/A
Allspring Innovation Fund - Class C
BRTNX69.45N/A
N/A
Bretton Fund
APDJX17.10N/A
N/A
Artisan International Small-Mid Advisor

RARE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been loosely correlated with CRNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RARE jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
+3.90%
CRNX - RARE
49%
Loosely correlated
+3.55%
IONS - RARE
47%
Loosely correlated
+0.24%
RVMD - RARE
47%
Loosely correlated
+1.57%
VCYT - RARE
46%
Loosely correlated
+1.08%
DNLI - RARE
45%
Loosely correlated
+1.85%
More